BLOOMAGE BIOTECHNOLOGY CORP LTD Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Bloomage BioTechnology Corporation Limited華 熙 生 物 科 技 有 限 公 司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 00963) RESULTS OF THE 2015 ANNUAL GENERAL MEETINGThe Board is pleased to announce that all the resolutions as set out in the AGM Notice were duly passed at the AGM held on 6 June 2016.
Reference is made to the circular dated 29 April 2016 (the "Circular") and the notice of 2015 annual general meeting (the "AGM") dated 29 April 2016 (the "AGM Notice") of Bloomage BioTechnology Corporation Limited (the "Company"). Unless otherwise defined, capitalized terms used herein shall have the same meanings as defined in the Circular.
RESULTS OF THE AGMThe board of directors of the Company (the "Board") announces that, at the AGM held at Victoria I, Level 2, Four Seasons Hotel, 8 Finance Street, Central, Hong Kong on 6 June 2016 at 3:00 p.m., poll voting was adopted for all of the resolutions as set out in the AGM Notice (the "Resolutions").
The Board is pleased to announce that the Resolutions were duly passed by the Shareholders by poll voting at the AGM. The poll results for the Resolutions are as follows.
Ordinary Resolutions | Number of Votes (%) | Total Votes | ||
For | Against | |||
1. | To receive, consider and adopt the audited consolidated accounts and reports of the directors and auditors of the Company and its subsidiaries for the year ended 31 December 2015 | 271,780,034 (100%) | 0 (0%) | 271,780,034 |
2. | To declare a final dividend of HK$2.7 cents per share for the year ended 31 December 2015 | 271,780,034 (100%) | 0 (0%) | 271,780,034 |
3. | To re-appoint KPMG as auditors to the Company and to authorise the board of directors of the Company to fix their remuneration | 271,780,034 (100%) | 0 (0%) | 271,780,034 |
4. | (a) To re-elect Mr. Jin Xuekun as an executive director of the Company and to authorise the board of directors of the Company to fix his director's remuneration | 271,117,309 (99.76%) | 662,725 (0.24%) | 271,780,034 |
(b) To re-elect Ms. Wang Aihua as an executive director of the Company and to authorise the board of directors of the Company to fix her director's remuneration | 271,780,034 (100%) | 0 (0%) | 271,780,034 | |
(c) To re-elect Mr. Yau Wai Yan as a non-executive director of the Company and to authorise the board of directors of the Company to fix his director's remuneration | 271,780,034 (100%) | 0 (0%) | 271,780,034 | |
Ordinary Resolutions | Number of Votes (%) | Total Votes | ||
For | Against | |||
(d) To re-elect Mr. Xue Zhaofeng as an independent non-executive director of the Company and to authorise the board of directors of the Company to fix his director's remuneration | 271,780,034 (100%) | 0 (0%) | 271,780,034 | |
5. | To grant a general mandate to the directors of the Company to allot, issue and deal with additional shares not exceeding 20% of the total number of Shares of the Company as at the date of passing this resolution | 233,013,060 (85.74%) | 38,766,974 (14.26%) | 271,780,034 |
6. | To grant a general mandate to the directors of the Company to repurchase shares not exceeding 10% of the total number of Shares of the Company as at the date of passing this resolution | 271,780,034 (100%) | 0 (0%) | 271,780,034 |
7. | To extend the general mandate granted to the directors of the Company to allot, issue and deal with additional shares in the share capital of the Company by an amount not exceeding the amount of the shares bought back by the Company | 233,015,160 (85.74%) | 38,764,874 (14.26%) | 271,780,034 |
8. | To approve the refreshment of the 10% limit on the total number of shares of the Company in issue which may be allotted and issued upon exercise of all options to be granted under the Share Option Scheme of the Company | 238,700,560 (87.83%) | 33,079,474 (12.17%) | 271,780,034 |
The description of the Resolutions above is by way of summary only. The full text appears in the AGM Notice.
As more than 50% of the votes were cast in favour of the Resolutions, the Resolutions were duly passed as ordinary resolutions of the Company at the AGM.
The Hong Kong branch share registrar and transfer office of the Company, Tricor Investor Services Limited was appointed as the scrutineer for the voting-taking at the AGM.
Notes:
The total number of shares of the Company in issue as at the date of the AGM was 361,834,834 shares of HK$0.01 each, which was the total number of shares entitling the holders to attend and vote for or against all the Resolutions at the AGM.
There was no share (i) entitling the holder to attend and abstain from voting in favour of; or (ii) requiring the holder to abstain from voting on, the Resolutions at the AGM.
No shareholders have stated their intention in the Circular to vote against the Resolutions or to abstain from voting at the AGM.
Hong Kong, 6 June 2016
By Order of the Board
Bloomage BioTechnology Corporation Limited Zhao YanChairman
As at the date of this announcement, the executive Directors are Ms. Zhao Yan, Mr. Jin Xuekun, Ms. Liu Aihua and Ms. Wang Aihua; the non-executive Director is Mr. Yau Wai Yan; the independent non-executive Directors are Ms. Zhan Lili, Mr. Li Junhong and Mr. Xue Zhaofeng.
Bloomage BioTechnology Corporation Ltd. published this content on 06 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 June 2016 11:34:09 UTC.
Original documenthttp://www.bloomagebio-tech.com/attachment/2016060619320100002534046_en.pdf
Public permalinkhttp://www.publicnow.com/view/10703188857D3F04DC90B5A5FE8DBC8FEFDD78E9
